Skip to main content
TipRanks
Go Ultimate75% OFF

Norman Charles Evans Insider Profile

4 Followers

Norman Charles Evans, Chief Financial Officer (maternity leave) at Cipher Pharmaceuticals, holds 24.28K shares in Cipher Pharmaceuticals (Ticker: CPHRF). Most recently, Norman Charles Evans Sold 10,000 shares of Cipher Pharmaceuticals on Jun 09, 2016 for an estimated value of ―.

Norman Charles Evans's Trading History

CPHRF
Cipher Pharmaceuticals
Jun 09, 2016Chief Financial Officer (maternity leave)Informative Sell―$233.58K
CPHRF
Insider Shares: 24.28K (9.28%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 09, 2016Informative SellC$0.0010,000C$0.00+27.70%―
Mar 21, 2016Uninformative SellC$0.00859C$0.00――
Sep 21, 2015Uninformative BuyC$20.00K3,636C$5.50――
May 28, 2015Informative SellC$0.005,000C$0.00+39.00%―
May 28, 2015Uninformative SellC$57.20K45,000C$1.27――

You May Also Like

Norman Charles Evans insider profile FAQ

What is the percentage of profitable transactions made by Norman Charles Evans?
The percentage of profitable transactions made by Norman Charles Evans is 83%.
What is the average return per transaction made by Norman Charles Evans?
The average return per transaction made by Norman Charles Evans is 36.50%.
What stocks does Norman Charles Evans hold?
Norman Charles Evans holds: CPHRF stocks.
What was Norman Charles Evans's most profitable transaction?
Norman Charles Evans’s most profitable transaction was an Informative Sell of CPHRF stock on September 25, 2014. The return on the trade was 59.80%.
What is Norman Charles Evans's role in Cipher Pharmaceuticals?
Norman Charles Evans's role in Cipher Pharmaceuticals is Chief Financial Officer (maternity leave).
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.